drugset / Trial / NCT02508155

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

NCT02508155 ↗

Phase 1 Completed 132 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to assess the safety, drug levels and effects on the body of MEDI7352, in subjects with painful osteoarthritis of the knee.

Timeline

Start
2015-11-17
Primary completion
2020-12-23
Completion
2020-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject MEDI7352 Unknown — Intravenous

Indications